OBJECTIVE: To study the factors influencing mother-infant vertical transmission of hepatitis B virus (HBV). METHODS: A total of 635 pregnant women with chronic hepatitis B or chronic asymptomatic HBV carriers were enrolled. The rate of HBV infection was compared between the infants born from the pregnant women of different HBV-DNA load, different ways of delivery and different liver functions at birth and 3 months after birth. The newborn infants were routinely injected with hepatitis B immunoglobulin (200 IU) and hepatitis B vaccine (10 μg) within 12 hrs of birth. The newborns presenting HBV infection within 24 hrs of birth by serum test were re-injected with hepatitis B immunoglobulin (200 IU) 14 days after birth. RESULTS: The rate of HBV infection in infants with maternal HBV-DNA load >105 copies/mL was higher than in those with maternal HBV-DNA load ≤105copies/mL at birth (14.4% vs 4.1%; P<0.01) and 3 months after birth (4.7% vs 0; P<0.01).The rate of HBV infection at 3 months was lower than at birth in both groups. The rate of HBV infection in infants born by natural labor was higher than in those born by caesarean birth at birth (P<0.05), however, by 3 months after birth, the rate of HBV infection between the two groups was similar. The rate of HBV infection was higher in infants born to chronic asymptomatic HBV carrier mothers than that in infants born to chronic hepatitis B mothers at birth (P<0.01), but there were no significant differences in the two groups 3 months later. CONCLUSIONS: The maternal HBV-DNA load is correlated with the rate of HBV infection of infants. It might thus be an effective way to reduce the rate of HBV infection in infants by decreasing maternal HBV-DNA load. With the administration of hepatitis B immunoglobulin and hepatitis B vaccine, the delivery way and the liver function of pregnant women may not to be factors influencing mother-infant HBV vertical transmission.
Key words
Hepatitis B virus /
Vertical transmission /
Newborn infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1]Salkic NN, Zildzic M, Muminhodzic K, Pavlovic-Calic N, Zerem E, Ahmetagic S, et al. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina[J]. Eur J Gastroenterol Hepatol, 2007, 19(2): 113-118.
[2]池美珠,王玉燕,帅茨霞.产前注射乙型肝炎免疫球蛋白预防乙型肝炎病毒宫内感染的临床研究[J].中国当代儿科杂志,2002,4(2):127-128.
[3]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[ J ].中华内科杂志,2006,45(2):162-170.
[4]潘文涛,尹玉竹,谌小卫,周水生.HBV宫内感染预测指标的探讨[J].中山大学学报(医学科学版),2010,31(1):110-113.
[5]徐红梅,刘作义.乙型肝炎病毒母婴传播及其阻断[J].实用儿科临床杂志,2005,9(20):835-837.
[6]van der Sarde MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination[J]. J Infect Dis, 2006, 193(11): 1528-1535.
[7]Kripke C. Hepatitis B vaccine for infant of HBsAgpositive mothers[J].Am Fam Physician, 2007, 75(1): 49-50.
[8]Choe BH, Lee JH, Jang YC, Jang CH, Oh KW, Kwon S, et al. Longtem therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better [J ]. J Pediatr Gasteroenterol Nutr, 2007, 44(1): 92-98.
[9]梁小丽.乙肝病毒母婴垂直传播临床特点分析[J].中国优生与遗传杂志,2009,17(7):61-62.
[10]李云华,杨鲁华,李志,张蕾,芦金凤.乙肝疫苗、乙肝免疫球蛋白联合剖宫产对主动乙型肝炎母婴传播的研究[J].临床肝胆病杂志,2006,22(2):138.
[11]李继军,王富珍,郑徽,梁晓峰.不同分娩方式对乙型肝炎病毒母婴传播的影响[J].中国计划免疫,2007,13(4):306-308.